U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C32H39N7O4
Molecular Weight 585.6966
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MOBOCERTINIB

SMILES

COC1=C(NC2=NC=C(C(=O)OC(C)C)C(=N2)C3=CN(C)C4=C3C=CC=C4)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C

InChI

InChIKey=AZSRSNUQCUDCGG-UHFFFAOYSA-N
InChI=1S/C32H39N7O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26/h9-13,16-20H,1,14-15H2,2-8H3,(H,34,40)(H,33,35,36)

HIDE SMILES / InChI

Molecular Formula C32H39N7O4
Molecular Weight 585.6966
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 10:21:30 UTC 2023
Edited
by admin
on Sat Dec 16 10:21:30 UTC 2023
Record UNII
39HBQ4A67L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MOBOCERTINIB
USAN   INN  
Official Name English
PROPAN-2-YL 2-(5-(ACRYLOYLAMINO)-4-((2-(DIMETHYLAMINO)ETHYL)(METHYL)AMINO)-2-METHOXYANILINO)-4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDINE-5-CARBOXYLATE
Systematic Name English
MOBOCERTINIB [USAN]
Common Name English
AP32788
Code English
mobocertinib [INN]
Common Name English
TAK-788
Code English
Mobocertinib [WHO-DD]
Common Name English
AP-32788
Code English
5-PYRIMIDINECARBOXYLIC ACID, 2-((4-((2-(DIMETHYLAMINO)ETHYL)METHYLAMINO)-2-METHOXY-5-((1-OXO-2-PROPEN-1-YL)AMINO)PHENYL)AMINO)-4-(1-METHYL-1H-INDOL-3-YL)-, 1-METHYLETHYL ESTER
Systematic Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 653018
Created by admin on Sat Dec 16 10:21:30 UTC 2023 , Edited by admin on Sat Dec 16 10:21:30 UTC 2023
Code System Code Type Description
CAS
1847461-43-1
Created by admin on Sat Dec 16 10:21:30 UTC 2023 , Edited by admin on Sat Dec 16 10:21:30 UTC 2023
PRIMARY
USAN
JK-22
Created by admin on Sat Dec 16 10:21:30 UTC 2023 , Edited by admin on Sat Dec 16 10:21:30 UTC 2023
PRIMARY
RXCUI
2570736
Created by admin on Sat Dec 16 10:21:30 UTC 2023 , Edited by admin on Sat Dec 16 10:21:30 UTC 2023
PRIMARY
EPA CompTox
DTXSID201336749
Created by admin on Sat Dec 16 10:21:30 UTC 2023 , Edited by admin on Sat Dec 16 10:21:30 UTC 2023
PRIMARY
PUBCHEM
118607832
Created by admin on Sat Dec 16 10:21:30 UTC 2023 , Edited by admin on Sat Dec 16 10:21:30 UTC 2023
PRIMARY
NCI_THESAURUS
C126752
Created by admin on Sat Dec 16 10:21:30 UTC 2023 , Edited by admin on Sat Dec 16 10:21:30 UTC 2023
PRIMARY
SMS_ID
300000010812
Created by admin on Sat Dec 16 10:21:30 UTC 2023 , Edited by admin on Sat Dec 16 10:21:30 UTC 2023
PRIMARY
FDA UNII
39HBQ4A67L
Created by admin on Sat Dec 16 10:21:30 UTC 2023 , Edited by admin on Sat Dec 16 10:21:30 UTC 2023
PRIMARY
DAILYMED
39HBQ4A67L
Created by admin on Sat Dec 16 10:21:30 UTC 2023 , Edited by admin on Sat Dec 16 10:21:30 UTC 2023
PRIMARY
INN
11183
Created by admin on Sat Dec 16 10:21:30 UTC 2023 , Edited by admin on Sat Dec 16 10:21:30 UTC 2023
PRIMARY
Related Record Type Details
INHIBITOR -> TARGET
Approved for treatment of EGFR EXON 20 insertions mutations in NSLC
Related Record Type Details
ACTIVE MOIETY